Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease

Open Label Study of TRx0014 in Alzheimer's Disease

NCT00684944 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

NCT02573740 ·Status: TERMINATED ·Phase: PHASE1

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

NCT03721705 ·Status: COMPLETED ·Phase: PHASE3

Open-label Extension for Phase 3 Clinical Trials of Simufilam

NCT05575076 ·Status: TERMINATED ·Phase: PHASE3

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

NCT03131453 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00105547 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

NCT03625401 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

NCT01350362 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

NCT03790982 ·Status: UNKNOWN ·Phase: PHASE2

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

NCT00574132 ·Status: COMPLETED ·Phase: PHASE3

Alzheimer's Tau Platform: Master Protocol

NCT06957418 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

NCT00895895 ·Status: TERMINATED ·Phase: PHASE2

Effect of AQW051 in Patients With Memory Impairment

NCT00582855 ·Status: TERMINATED ·Phase: PHASE2

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo

NCT01827982 ·Status: COMPLETED ·Phase: PHASE1

Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study

NCT05809908 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of Seltorexant in Participants With Probable Alzheimer's Disease

NCT05307692 ·Status: COMPLETED ·Phase: PHASE2

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

NCT01369225 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

NCT00566397 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

NCT02626572 ·Status: COMPLETED ·Phase: PHASE2

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

NCT05607615 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

NCT02079909 ·Status: COMPLETED ·Phase: PHASE2

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

NCT05161715 ·Status: COMPLETED ·Phase: PHASE2

Tricaprilin In Age-Associated Memory Impairment

NCT00355550 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

NCT03462121 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

NCT04867616 ·Status: COMPLETED ·Phase: PHASE2